Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

Dramatic Bone Response in Prostate CA

Discussion in 'Other Health News and Research' started by shrewsbury, Feb 21, 2011.

  1. shrewsbury

    shrewsbury member

    Messages:
    1,541
    Likes:
    63
    I wonder if this will become relevant with XMRV.

    "Dramatic resolution of bone metastases occurred in 85% of patients with castration-resistant prostate cancer treated with a wide-spectrum tyrosine kinase inhibitor, according to preliminary study data."

    "the bone effects of cabozantinib are not limited to castration-resistant prostate cancer. Benefits have also been observed in breast cancer, melanoma, thyroid cancer, and renal cell cancer."

    http://www.medpagetoday.com/Meeting...eadlines&utm_source=WC&em=leelaplay@gmail.com
     

See more popular forum discussions.

Share This Page